Annual Current Liabilities
$7.85 M
-$208.60 K-2.59%
31 December 2023
Summary:
Immuneering annual total current liabilities is currently $7.85 million, with the most recent change of -$208.60 thousand (-2.59%) on 31 December 2023. During the last 3 years, it has risen by +$5.59 million (+247.78%). IMRX annual current liabilities is now -2.59% below its all-time high of $8.05 million, reached on 31 December 2022.IMRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$6.92 M
+$138.90 K+2.05%
30 September 2024
Summary:
Immuneering quarterly total current liabilities is currently $6.92 million, with the most recent change of +$138.90 thousand (+2.05%) on 30 September 2024. Over the past year, it has increased by +$1.30 million (+23.08%). IMRX quarterly current liabilities is now -14.08% below its all-time high of $8.05 million, reached on 31 December 2022.IMRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMRX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.6% | +23.1% |
| 3 y3 years | +247.8% | +31.4% |
| 5 y5 years | - | - |
IMRX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2.6% | +247.8% | -14.1% | +88.4% |
| 5 y | 5 years | -2.6% | +1452.6% | -14.1% | +206.8% |
| alltime | all time | -2.6% | +1452.6% | -14.1% | +206.8% |
Immuneering Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.92 M(+2.0%) |
| June 2024 | - | $6.78 M(+31.0%) |
| Mar 2024 | - | $5.18 M(-34.0%) |
| Dec 2023 | $7.85 M(-2.6%) | $7.85 M(+39.5%) |
| Sept 2023 | - | $5.62 M(+2.6%) |
| June 2023 | - | $5.48 M(-0.8%) |
| Mar 2023 | - | $5.53 M(-31.4%) |
| Dec 2022 | $8.05 M | $8.05 M(+11.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $7.26 M(+90.9%) |
| June 2022 | - | $3.80 M(+3.4%) |
| Mar 2022 | - | $3.67 M(-34.8%) |
| Dec 2021 | $5.63 M(+149.7%) | $5.63 M(+7.0%) |
| Sept 2021 | - | $5.27 M(+9.0%) |
| June 2021 | - | $4.83 M(+75.2%) |
| Mar 2021 | - | $2.76 M(+22.3%) |
| Dec 2020 | $2.26 M(+346.4%) | $2.26 M |
| Dec 2019 | $505.30 K | - |
FAQ
- What is Immuneering annual total current liabilities?
- What is the all time high annual current liabilities for Immuneering?
- What is Immuneering annual current liabilities year-on-year change?
- What is Immuneering quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Immuneering?
- What is Immuneering quarterly current liabilities year-on-year change?
What is Immuneering annual total current liabilities?
The current annual current liabilities of IMRX is $7.85 M
What is the all time high annual current liabilities for Immuneering?
Immuneering all-time high annual total current liabilities is $8.05 M
What is Immuneering annual current liabilities year-on-year change?
Over the past year, IMRX annual total current liabilities has changed by -$208.60 K (-2.59%)
What is Immuneering quarterly total current liabilities?
The current quarterly current liabilities of IMRX is $6.92 M
What is the all time high quarterly current liabilities for Immuneering?
Immuneering all-time high quarterly total current liabilities is $8.05 M
What is Immuneering quarterly current liabilities year-on-year change?
Over the past year, IMRX quarterly total current liabilities has changed by +$1.30 M (+23.08%)